Search results
2 kwi 2024 · Universal vaccination: To reduce community transmission and protect individuals with HIV, this committee agrees with the CDC recommendations for universal vaccination against COVID-19 for adults (≥18 years old) with HIV, regardless of prior history of COVID-19 infection.
19 lip 2024 · Eligible participants were healthy women (assigned female sex at birth) aged 18–35 years who had had sexual intercourse with a male partner two or more times in the 30 days before screening, were at increased risk of acquiring HIV-1, and were HIV-1-negative and HIV-2-negative.
25 kwi 2023 · HPV vaccination may have a relevant impact in settings featured by low HIV prevention coverage, where mathematical models showed that the cumulative number of HIV infections that could be averted by HPV vaccination over 50 years could reach up to 27,812 cases in women and 14,693 cases in men .
22 gru 2022 · Vaccination is most effective in patients with early HIV infection and in those on ART who are virologically suppressed and have restored CD4 function. This topic will review the approach to vaccination for vaccine-preventable diseases in persons with HIV.
28 sie 2019 · This phase IV randomized controlled observer-blind study assessed immunogenicity and safety of two HPV vaccines (AS04-HPV-16/18 vs. 4vHPV) given in WLWH (stage 1) and HIV- females aged 15–25 years.
This review summarizes available data on the use of the HPV vaccines among HIV infected women. The immunogenicity and safety of the vaccine is highlighted and in particular, barriers to vaccination among HIV infected women are discussed.
10 sty 2024 · People with HIV presenting with CD4 count <200 cells/mm 3 with ongoing risk for HAV should be immunized and assessed for antibody response 1 to 2 months after completion of the series. For people with HIV without risk factors, waiting for a CD4 count >200 cells/mm 3 is an option.
